New Triple-Drug attack on tough blood cancer
Disease control
Recruiting now
This study is testing a combination of three drugs—acalabrutinib, venetoclax, and obinutuzumab—for people with mantle cell lymphoma, a type of blood cancer. It aims to see if this combination is safe and effective for patients whose cancer has come back after treatment or who hav…
Phase: PHASE1, PHASE2 • Sponsor: Austin I Kim • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC